PCOS has transformed into PMOS, signifying a radical shift in focus towards a comprehensive understanding of this condition.
The condition, until recently, was primarily classified as a gynecological issue. The new term, “Polycystic Metabolic Ovarian Syndrome” (PMOS), emphasizes its nature as a complex endocrine disorder with systemic effects.
New Definition After Years of Research
Under the guidance of Prof. Helena Teede, more than 14,000 patients and professionals collaborated to redefine this syndrome. Their findings were published in the prestigious journal, Lancet, in 2025.
This new terminology not only highlights the metabolic component but also underscores critical factors such as insulin resistance and obesity risks alongside irregular periods and elevated testosterone levels. Importantly, this definition delineates between preclinical and clinical stages of obesity for the first time.
Early Detection Aims to Reduce the Diagnostic Gap
The UK’s National Institute for Health and Care Excellence (NICE) released a draft guideline on July 2, 2026, recommending systematic screening of all patients experiencing irregular menstrual cycles for PMOS.
The reason for this recommendation is alarming; according to the WHO, up to 70% of affected individuals remain undiagnosed worldwide. The new guidelines propose annual checks for both symptoms and medication management.
Furthermore, doctors are advised to focus on long-term risks, including sleep apnea, fatty liver disease, and mental health challenges like depression. For patients wishing to conceive, supplementation with Myo-Inositol is encouraged, with clinical observations indicating an increase in ovulation rates by up to 275%.
Nutritional Adjustments: A Key to Management
Given that hormonal disorders like PMOS are often associated with a heightened risk of metabolic diseases, early dietary adjustments are crucial. For patients managing Type 2 diabetes through targeted dietary changes, insights can be found in free guides available online.
Prioritizing Lifestyle Over Laser Treatments
The implementation of these new standards necessitates clear economic decisions. While IVF treatments will continue to be available under specific criteria, the guidelines oppose funding for laser hair removal due to substantial annual costs that can reach £100 million.
Instead, the medical community is shifting its focus toward lifestyle management and treating metabolic disorders with medication. Early intervention is essential to prevent complications such as Type 2 diabetes.
The Role of Exercise
In addition to diet, regular physical activity plays a pivotal role in stabilizing blood sugar levels in those affected by hormone-related metabolic issues. Simple 3-minute exercises that can be incorporated into daily life are available in various free resources.
Who is Affected?
PMOS currently affects about 1 in 8 women of reproductive age, translating to a prevalence of approximately 13%. In the United Kingdom alone, 3-4 million women are impacted.
The guidelines highlight a significantly higher prevalence among Black, Asian, and ethnically mixed populations. Recommendations for early detection extend to individuals starting from age ten, including trans men and non-binary individuals.
The consultation phase for the new standards will continue until August 11, 2026, with a final guideline set for release on December 9, 2026. Concurrently, data from DAK indicates that eating disorders among young girls have surged by 50% since 2019, further underscoring the need for a holistic understanding of both hormonal and psychological factors.
